Bodevision

Mutual fund distribution, insurance, and financial services in India.

About Bodevision

Bodevision is a Healthcare company. It operates as a mutual fund distribution, insurance, and financial services in India. It operates in the Healthcare and Financial Services sectors. Its Indian entity Bodevision Investor Services Private Limited reported revenue of β‚Ή5.08 Cr. Bodevision offers products and services including Mutual Fund Distribution and Life Insurance. Its focus areas include Finance, Insurance Services, Life and Health and Product Distribution.

Company details

Bodevision Investor Services Pvt. Ltd. is recognized as an AMFI registered entity that delivers client-centered financial solutions, where goals are defined through collaborative discussions and strategies are curated for objective achievement. A commitment is maintained to personalized services, technology-driven platforms for paperless investments, and adherence to ethical standards and compliance. Services encompass mutual funds, fixed deposits, life and health insurance, retirement, and child savings, all while ensuring data security and risk disclosures are provided to clients.

  • Sectors
    Healthcare
    Financial Services
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Legal Name Bodevision Investor Services Pvt. Ltd
  • Date of Incorporation 25 Apr, 2011
  • Jurisdiction Kanpur, Uttar Pradesh, India
Key Metrics
  • Annual Revenue
    ₹5.08 Cr

    FY 2025 · +31% YoY

  • Net Profit
    ₹1.81 Cr

    FY 2025 · 36% margin

  • EBITDA
    ₹2.56 Cr

    FY 2025 · 50% margin

Products & Services of Bodevision

Bodevision offers a comprehensive portfolio of products and services, including Mutual Fund Distribution and Life Insurance.

Mutual Fund Distribution
Investment Services

Mutual fund distribution services are offered to clients for wealth growth through tailored investment solutions

Life Insurance
Insurance Services

Life insurance products are provided as contracts to protect against specific risks

Board of directors of Bodevision Investor Services Private Limited (Bodevision)

Bodevision Investor Services Private Limited is the primary company behind Bodevision. The board of Bodevision Investor Services Private Limited currently have 2 directors; the longest-serving is Alok Agarwal, appointed in 2011. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Alok Agarwal
DIN 02746044
Managing Director25 Apr 201115 yrs 5 moBodevision Investor Services Private Limited
Ritu Agarwal
DIN 06789427
Whole-time director20 Jan 201412 yrs 9 moBodevision Investor Services Private Limited

Financials of Bodevision

Figures of Bodevision Investor Services Private Limited, the primary company behind Bodevision, for FY 2025. Revenue was ₹5.08 Cr (+31% year on year). Net profit was ₹1.81 Cr (36% margin). EBITDA was ₹2.56 Cr (50% margin). Revenue has grown at a compounded annual rate of +21% over three years and +20% over five years.

  • ₹5.08 CrRevenue · FY 2025 · +31% YoY
  • ₹1.81 CrNet profit · 36% margin
  • ₹2.56 CrEBITDA · 50% margin
  • ₹2 LakhPaid-up capital
  • +21%Revenue CAGR, 3 years
  • +20%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Bodevision Investor Services Private Limited are on its company page.

Premium access

Detailed financial statements for Bodevision

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

10 companies that operate in the same segment as Bodevision (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Pharmaceutical products are manufactured and marketed worldwide.
1891Kenilworth, Warwickshire, United Kingdom–USD 64.93 B781
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United States–USD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United States–USD 61.16 B55,000
Traditional pharmaceutical medicines are developed for multiple health fields.
1876United States–USD 65.18 B47,000
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
1987Foster City, California, United States–USD 29.45 B17,600
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology.
1993San Francisco, California, United StatesUSD 213.52 MUSD 29.62 M225
Developer of medical devices, generic pharmaceuticals, and nutrition products
1888Libertyville, Illinois, United States–USD 44.33 B3,710
Medicines and health products are retailed through pharmacy outlets.
2006Hyderabad, Telangana, IndiaUSD 268.78 MUSD 734.57 M25,010
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bodevision

The primary company behind Bodevision, Bodevision Investor Services Private Limited, reported revenue of β‚Ή5.08 Cr for FY 2025, up 31% year on year.

Bodevision Investor Services Pvt. Ltd. is recognized as an AMFI registered entity that delivers client-centered financial solutions, where goals are defined through collaborative discussions and strategies are curated for objective achievement. A commitment is maintained to personalized services, technology-driven platforms for paperless investments, and adherence to ethical standards and compliance. Services encompass mutual funds, fixed deposits, life and health insurance, retirement, and child savings, all while ensuring data security and risk disclosures are provided to clients.

Bodevision offers Mutual Fund Distribution and Life Insurance.

Bodevision operates through Bodevision Investor Services Private Limited.

The legal entities of Bodevision currently have 2 directors, including Alok Agarwal, Ritu Agarwal.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available